Yale researchers have mouse data showing that vaginal application of two chemokines recruits memory T cells into vaginal tissue and improves the protective effect of an HSV-2 vaccine. The team is now working to prolong the duration of the chemokines' effects and wants to extend the strategy to HIV prophylaxis.